146 related articles for article (PubMed ID: 12424857)
1. Combined modality therapy of esophageal cancer--standard of care?
Urba S
Surg Oncol Clin N Am; 2002 Apr; 11(2):377-86. PubMed ID: 12424857
[TBL] [Abstract][Full Text] [Related]
2. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
3. Treatment of localized esophageal cancer.
Brenner B; Ilson DH; Minsky BD
Semin Oncol; 2004 Aug; 31(4):554-65. PubMed ID: 15297946
[TBL] [Abstract][Full Text] [Related]
4. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
5. Esophageal cancer.
Coia LR; Sauter ER
Curr Probl Cancer; 1994; 18(4):189-247. PubMed ID: 7533069
[TBL] [Abstract][Full Text] [Related]
6. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.
Iyer R; Wilkinson N; Demmy T; Javle M
Ann Surg Oncol; 2004 Jul; 11(7):665-73. PubMed ID: 15197012
[TBL] [Abstract][Full Text] [Related]
7. Combined-modality treatment of esophageal cancer.
Urba S
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 9):63-7. PubMed ID: 9330411
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Shinoda M; Hatooka S; Mori S; Mitsudomi T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiation for locally advanced resectable carcinoma of the esophagus: A single-center experience from India with a brief review of the literature.
Krishnamurthy A; Mohanraj N; Radhakrishnan V; John A; Selvaluxmy G
Indian J Cancer; 2017; 54(4):646-651. PubMed ID: 30082551
[TBL] [Abstract][Full Text] [Related]
11. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
Ohtsu A
Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
[TBL] [Abstract][Full Text] [Related]
12. Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer.
Kim JH; Choi EK; Kim SB; Park SI; Kim DK; Song HY; Jung HY; Min YI
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):1-12. PubMed ID: 11316540
[TBL] [Abstract][Full Text] [Related]
13. ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
Hoeppner J; Lordick F; Brunner T; Glatz T; Bronsert P; Röthling N; Schmoor C; Lorenz D; Ell C; Hopt UT; Siewert JR
BMC Cancer; 2016 Jul; 16():503. PubMed ID: 27435280
[TBL] [Abstract][Full Text] [Related]
14. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
15. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy in the multimodality management of esophageal cancer.
Encheva E; Kolev N; Tonev A; Ignatov V; Shterev S; Petrov D; Zlatarov A; Koleva I; Chaushev B; Kirilova T; Ivanov K
Khirurgiia (Sofiia); 2014; (3):12-9. PubMed ID: 25799618
[TBL] [Abstract][Full Text] [Related]
18. Management of locoregional stage esophageal cancer: a single center experience.
Javle MM; Nwogu CE; Donohue KA; Iyer RV; Brady WE; Khemka SV; Smith JL; Demmy TL; Yang GY; Nava HR
Dis Esophagus; 2006; 19(2):78-83. PubMed ID: 16643174
[TBL] [Abstract][Full Text] [Related]
19. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
Algan O; Coia LR; Keller SM; Engstrom PF; Weiner LM; Schultheiss TE; Hanks GE
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):753-61. PubMed ID: 7790262
[TBL] [Abstract][Full Text] [Related]
20. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer--a review.
Urschel JD; Ashiku S; Thurer R; Sellke FW
Dis Esophagus; 2003; 16(2):60-5. PubMed ID: 12823198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
